Standardized classification and framework for reporting and interpreting medication non-adherence in clinical trials.
作者信息
Senatore Fortunato F, Califf Robert M
机构信息
Division of Cardiovascular and Renal Products, US Food and Drug Administration, Silver Spring, MD, USA.
Departmet of Medicine, Duke University School of Medicine, Durham, NC, USA.
出版信息
Eur Heart J. 2019 Jul 1;40(25):2086-2088. doi: 10.1093/eurheartj/ehy759.
Abstract
摘要
相似文献
1
Standardized classification and framework for reporting and interpreting medication non-adherence in clinical trials.临床试验中药物不依从性报告与解读的标准化分类及框架
Eur Heart J. 2019 Jul 1;40(25):2086-2088. doi: 10.1093/eurheartj/ehy759.
2
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).心血管临床试验中报告、解释和分析药物不依从的标准化分类和框架：不依从学术研究联盟（NARC）的共识报告。
Eur Heart J. 2019 Jul 1;40(25):2070-2085. doi: 10.1093/eurheartj/ehy377.
3
Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic review.评估透析患者心血管或死亡率结局的随机对照试验中的药物依从性：一项系统评价。
BMC Nephrol. 2017 Jan 31;18(1):42. doi: 10.1186/s12882-017-0449-1.
4
ESPACOMP Medication Adherence Reporting Guidelines (EMERGE): a reactive-Delphi study protocol.ESPACOMP药物依从性报告指南（EMERGE）：一项德尔菲反应性研究方案
BMJ Open. 2017 Feb 10;7(2):e013496. doi: 10.1136/bmjopen-2016-013496.
5
Adherence reporting in clinical trials of type 2 Diabetes Metellius in the field of Traditional Chinese Medicine.中医领域2型糖尿病Metellius临床试验中的依从性报告。
J Tradit Chin Med. 2017 Feb;37(1):140-2. doi: 10.1016/s0254-6272(17)30037-7.
6
Reply: Medication Adherence and Cardiovascular Outcomes.回复：药物依从性与心血管结局
J Am Coll Cardiol. 2017 Feb 7;69(5):599-600. doi: 10.1016/j.jacc.2016.10.074.
7
Medication Adherence and Cardiovascular Outcomes.药物依从性与心血管结局
J Am Coll Cardiol. 2017 Feb 7;69(5):598-599. doi: 10.1016/j.jacc.2016.09.985.
8
Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.风湿病学中的结局指标 - 药物依从性干预措施（OMERACT - 依从性）：风湿病学药物依从性干预试验的核心领域集：5期研究方案
Trials. 2018 Mar 27;19(1):204. doi: 10.1186/s13063-018-2565-z.
9
The ABC taxonomy for medication adherence translated into French and German.用于药物依从性的ABC分类法已翻译成法语和德语。
Br J Clin Pharmacol. 2020 Apr;86(4):734-744. doi: 10.1111/bcp.14172. Epub 2020 Jan 23.
10
Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: a systematic review of randomized trials.促进药物使用监测和简短信息传递的干预措施对2型糖尿病患者药物依从性的影响：随机试验的系统评价
Diabet Med. 2016 May;33(5):565-79. doi: 10.1111/dme.12987. Epub 2015 Nov 17.
本文引用的文献
1
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).心血管临床试验中报告、解释和分析药物不依从的标准化分类和框架：不依从学术研究联盟（NARC）的共识报告。
Eur Heart J. 2019 Jul 1;40(25):2070-2085. doi: 10.1093/eurheartj/ehy377.
2
Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.改善心脏代谢疾病的药物依从性：实际与监管意义
J Am Coll Cardiol. 2017 Jan 31;69(4):437-451. doi: 10.1016/j.jacc.2016.11.034.
3
Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.评估药物依从性对长期心血管结局的影响。
J Am Coll Cardiol. 2016 Aug 23;68(8):789-801. doi: 10.1016/j.jacc.2016.06.005.
4
Exploring the ethical and regulatory issues in pragmatic clinical trials.探讨实用临床试验中的伦理和监管问题。
Clin Trials. 2015 Oct;12(5):436-41. doi: 10.1177/1740774515598334. Epub 2015 Sep 15.
5
The relationship of disease severity, health beliefs and medication adherence among HIV patients.
AIDS Care. 2000 Aug;12(4):387-98. doi: 10.1080/09540120050123783.
6
Compliance in clinical trials: impact on design, analysis and interpretation.临床试验中的依从性：对设计、分析和解释的影响。
Epilepsy Res Suppl. 1988;1:125-33.
Zotero 插件